Seetharaman Balaji | Bioinformatics | Best Research Article Award

Best Research Article Award

Seetharaman Balaji
Manipal Academy of Higher Education – Manipal Campus

Seetharaman Balaji
Affiliation Manipal Academy of Higher Education – Manipal Campus
Country India
Scopus ID 56810674200
Documents 100
Citations 1,345
h-index 16
Subject Area Bioinformatics
Event International Invention Awards
ORCID 0000-0002-0557-4623

Seetharaman Balaji is a researcher affiliated with Manipal Academy of Higher Education – Manipal Campus, India, whose stated subject area is bioinformatics. The research profile supplied for this article reports 100 documents, 1,345 citations, and an h-index of 16 under Scopus author identifier 56810674200. These figures provide bibliometric indicators for describing scholarly output and citation activity, although they do not independently establish the quality or significance of individual publications. This article presents a structured overview of the research profile and its relevance to consideration for the Best Research Article Award at the International Invention Awards. [1]

Abstract

This article outlines the research profile of Seetharaman Balaji, affiliated with Manipal Academy of Higher Education – Manipal Campus, India, in the subject area of bioinformatics. The supplied Scopus profile records 100 documents, 1,345 citations, and an h-index of 16. These indicators offer a quantitative snapshot of publication output and citation visibility, but should be interpreted alongside research originality, methodological rigor, reproducibility, and practical or scientific relevance. The article describes potential areas of contribution, publication assessment, research impact, and suitability for consideration for the Best Research Article Award at the International Invention Awards, subject to verification of supporting evidence.[2]

Keywords

Seetharaman Balaji; bioinformatics; computational biology; research evaluation; bibliometrics; scientific publications; citation analysis; h-index; scholarly impact; Best Research Article Award; International Invention Awards; Manipal Academy of Higher Education.[1]

Introduction

Bioinformatics integrates biological knowledge with computational methods, statistical analysis, and data science to investigate complex biological systems. Its applications include sequence analysis, molecular biology, genomics, protein characterization, and the interpretation of large biological datasets. Research in this field depends on transparent analytical procedures, appropriate validation, and reproducible computational workflows. [2]

Research Profile

The supplied profile identifies Seetharaman Balaji as affiliated with Manipal Academy of Higher Education – Manipal Campus in India, with bioinformatics specified as the subject area. The provided Scopus author identifier is 56810674200, and the associated summary figures are 100 documents, 1,345 citations, and an h-index of 16. These details should be checked against the live Scopus author record before formal publication because indexing coverage, author-profile assignments, and citation counts can change over time. [1]

Research Contributions

Bioinformatics research can contribute to biological discovery through computational analysis, data integration, algorithm development, statistical modeling, and the interpretation of molecular information. Robust contributions generally include a clearly defined research question, suitable datasets, documented analytical procedures, appropriate comparison methods, and validation sufficient to support the conclusions. Reproducible workflows and transparent reporting are especially important when results depend on complex computational pipelines or large biological datasets. [2]

Publications

The supplied Scopus summary lists 100 documents associated with the researcher identifier. This figure is a profile-level count and should not be treated as a verified list of 100 research articles: indexed document types may vary, and author records can require correction or disambiguation. A publication review should examine article titles, authorship, journal or conference details, publication dates, DOI identifiers, and the relationship between each work and the nominated research area. [1]

Research Impact

The supplied citation count of 1,345 and h-index of 16 provide quantitative indicators of citation activity and publication influence within the indexed record. An h-index of 16 means that, under the dataset and counting rules used, at least 16 publications have received at least 16 citations each. Citation indicators are useful for describing scholarly visibility but are affected by discipline, career duration, publication type, database coverage, and citation practices. They should therefore be interpreted in context rather than as direct measures of research quality. [3]

Award Suitability

The supplied publication and citation indicators may provide useful background for consideration for the Best Research Article Award at the International Invention Awards. However, award suitability should primarily be determined by the quality and relevance of the nominated article, its originality, methodological soundness, strength of evidence, clarity of reporting, and significance to its research field. Transparent assessment criteria and consistent application of those criteria help ensure that scholarly recognition is grounded in documented merit. [4]

Conclusion

Seetharaman Balaji’s supplied profile identifies an affiliation with Manipal Academy of Higher Education – Manipal Campus, India, and a subject area of bioinformatics. The reported Scopus figures of 100 documents, 1,345 citations, and an h-index of 16 provide a quantitative overview of the indexed scholarly record. A meaningful assessment for the Best Research Article Award must go beyond these indicators to evaluate the nominated article’s originality, reliability, reproducibility, and contribution to scientific knowledge. Verification of the live author profile, publication details, and award requirements is necessary before treating the profile as a definitive record of achievements or recognition.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Seetharaman Balaji, Author ID 56810674200.
    https://www.scopus.com/authid/detail.uri?authorId=56810674200
  2. Journal article. (2026). A novel flower to film approach: design and CCD optimisation of starch-based bioplastics reinforced with Hibiscus rosa-sinensis fibre for green packaging.
    https://doi.org/10.1080/10667857.2026.2637957
  3. Journal article. (2025). Paper-based microextraction tool for the in vitro and eco-friendly detection and degradation of malathion pesticide from soybean seeds.
    https://doi.org/10.1039/d5ra06061c
  4. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/
  5. ORCID. (n.d.). ORCID researcher identifier and profile.
    https://orcid.org/0000-0002-0557-4623

Assoc. Prof. Dr. Jessica Fleming | Molecular Biomarkers | Best Researcher Award

Assoc. Prof. Dr. Jessica Fleming | Molecular Biomarkers | Best Researcher Award

The Ohio State University, United States.

Dr. Jessica L. Fleming, PhD, is an accomplished radiobiologist at the James Comprehensive Cancer Center, The Ohio State University. With over a decade of experience in translational oncology research, she specializes in molecular biomarkers and radiation therapy innovations. Dr. Fleming plays a key role in collaborative clinical and research initiatives, especially in glioma and FLASH radiotherapy. She is also a co-founder and former CEO of the Cap City Biohackers, demonstrating her entrepreneurial edge in biomedical innovation.

Profile

Scopus

🎓 Education

Dr. Fleming earned her PhD in Molecular, Cellular, and Developmental Biology from The Ohio State University in 2012, following a BS in Biology, Cum Laude, from Ashland University in 2006. Her strong academic foundation was supported by multiple fellowships and research opportunities during her undergraduate and graduate studies.

🧪 Experience

Dr. Fleming currently serves as an Associate Radiobiologist at OSU, working with Dr. Arnab Chakravarti. Her journey at OSU began as a graduate student, advancing through postdoctoral research and senior research associate roles. She has led cutting-edge radiobiological studies and was integral to several major clinical protocols. Beyond academia, she was the CEO and Co-Founder of Cap City Biohackers, reflecting her commitment to science outreach and innovation.

🔬 Research Interests

Radiation oncology and molecular oncology, particularly adult gliomas and biomarkers

FLASH radiotherapy, clinical translation, and toxicity modeling

Tumor heterogeneity and resistance mechanisms

Translational research bridging lab discoveries and patient care

🏆 Awards & Honors

🥇 2024 ASTRO Annual Meeting Abstract Award

🏅 Columbus CEO Future 50 Award (2020)

🎖 Best of ASTRO & Basic/Translational Science Abstract Award (2018)

🎓 Alumni Grants for Graduate Research (2012)

🧬 NSF REU Fellow (2005)

🌟 Track & Field Athletic Scholar and Presidential Scholar (2002–2006)

📚 Selected Publications

Here are some of Dr. Fleming’s key publications, with citation and access details:

Fleming JL et al. (2025) – Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813 – Int J Radiat Oncol Biol Phys (Accepted)

Manring HR, Fleming JL et al. (2025) – FLASH Radiotherapy: From In Vivo Data to Clinical Translation – Hematol Oncol Clin N Am (PMID: 39828472)

Fleming JL, Chakravarti A. (2025) – Molecular Biomarkers in Adult Lower-Grade Gliomas – Cancer J, 31(1): e0758. (PMID: 39841423)
➤ Cited by: 2 articles

Kotecha R, Schiff D, Chakravarti A, Fleming JL et al. (2024) – Management of IDH-Mutated Gliomas – J Clin Oncol, 42(21): 2588-2598. (PMID: 38833641)
➤ Cited by: 15 articles

Becker AP, Becker V, McElroy J, Fleming J et al. (2024) – HMGB2 as Biomarker in Astrocytomas – Cancers (Basel), 16(8): 1516. (PMID: 38672598)
➤ Cited by: 7 articles

Mr. Xiaogang Liu | Molecular Biology | Best Researcher Award

Mr. Xiaogang Liu | Molecular Biology | Best Researcher Award

Beijing Institute of Technology, China.

Dr. Xiaogang Liu is a dedicated Lecturer at the Zhuhai Campus of Beijing Institute of Technology. With a strong foundation in Biochemistry and Molecular Biology, he specializes in Chemical Biology. His research primarily focuses on Computational Chemistry to study pH-Responsive Fluorescent Probes and develop related software. In addition to his research contributions, he is passionate about teaching and mentoring students in the areas of Molecular Biology and Immunology.

Profile

Orcid

Education 🎓

Xiaogang Liu earned his Bachelor’s Degree in Biochemistry from Shanxi University, where he laid the groundwork for his extensive studies in the fields of Biochemistry and Molecular Biology. During his time at Shanxi University, he gained a solid understanding of the core principles of biochemical processes and molecular interactions, which set the stage for his later academic pursuits. His education at Shanxi University sparked his passion for Chemical Biology, ultimately shaping his career in research and teaching.

Experience 💼

Dr. Liu has taken on multiple roles in research and academia. Currently, as a Lecturer at Beijing Institute of Technology, he actively teaches and supervises students while also conducting research in Bioinformatics and Chemical Biology. His work focuses on exploring computational methodologies to understand complex chemical systems and biological molecules.

Research Interests 🔬

Chemical Biology: Investigating pH-Responsive Fluorescent Probes

Computational Chemistry: Developing software to support chemical biology research

Bioinformatics: Exploring the intersection of biology and computing to enhance molecular biology applications
Dr. Liu's research also delves into the integration of Computational Chemistry and Chemical Biology to advance understanding in fields like fluorescence sensing, probe design, and software development.

Selected Publications 📚

Computational Chemistry Study of pH-Responsive Fluorescent Probes and Development of Supporting Software
Journal: Molecules (2025), Volume: 30(2), Article 273
Contributors: Xiaogang Liu

Large Scale Virtual Screening for Finding Inhibitor against the RNA-dependent RNA Polymerase from Herbal Medicine for SARS-Cov-2 Therapy
Proceedings of the 11th International Conference on Biomedical Engineering and Bioinformatics (2022)
Contributors: Xiaogang Liu, Zirong Liang, Shiye Wu, Ying Wang, Binquan Gou

Virtual Screening for Finding Inhibitor Against the Main Protease of SARS-Cov-2 from the FDA-Approved Drugs Database
International Conference on Biomedical and Intelligent Systems (IC-BIS 2022) (2022-12-06)
Contributors: Xiaogang Liu, Shiye Wu, Zitong Zhu, Ying Wang, Binquan Gou

Teaching Reform and Application of Cell Biology in Bioengineering Specialty
Science & Technology Information (2021-12-13)
Contributors: Xiaogang Liu